Skip to main content

Want a detailed portfolio tracker?

Immix Biopharma (IMMX) P/E (2021 - 2026)

Immix Biopharma (IMMX) P/E from Dec 16, 2021 to Jun 12, 2026. The TTM Immix Biopharma (IMMX) P/E is -6.99. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Immix Biopharma (IMMX)

YearP/EChange
2026-6.99+57.91%
2025-4.43+59.85%
2024-2.77-70.91%
2023-9.52+747.86%
2022-1.12-30.49%
2021-1.62N/A

Comparison Immix Biopharma (IMMX) P/E with competitors

Immix Biopharma (IMMX) P/E is -6.99.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Therapeutics Ltd0.13-101.85%
FGENFibroGen Inc0.24-103.43%
TRAWTraws Pharma Inc0.47-106.76%
FBIOFortress Biotech Inc0.71-110.13%
CHRSCoherus Biosciences Inc0.80-111.46%
ORMPOramed Pharmaceuticals Inc1.37-119.59%
AGENAgenus Inc1.84-126.37%
VIVSVivoSim Labs Inc2.32-133.17%
INVAInnoviva Inc3.31-147.39%
CRMDCorMedix Inc3.78-154.04%
VXRTVaxart Inc3.95-156.51%
ABEOAbeona Therapeutics Inc3.96-156.64%
SRPTSarepta Therapeutics Inc4.19-159.90%
CVACCureVac N.V.4.45-163.57%
GLPGGalapagos NV4.86-169.48%
ABUSArbutus Biopharma Corp5.06-172.29%
RIGLRigel Pharmaceuticals5.16-173.76%
CGENCompugen Ltd5.24-174.98%
ZVRAZevra Therapeutics Inc6.13-187.69%
OMEROmeros Corporation9.11-230.23%
PLXProtalix BioTherapeutics Inc9.21-231.67%
SPROSpero Therapeutics Inc9.31-233.07%
AUPHAurinia Pharmaceuticals Inc9.32-233.32%
ACADAcadia Pharmaceuticals Inc9.62-237.50%
TBPHTheravance Biopharma Inc11.86-269.54%
ADMAAdma Biologics Inc12.13-273.48%
SABSSAB Biotherapeutics Inc12.93-284.83%
HRMYHarmony Biosciences Holdings Inc14.05-300.91%
REGNRegeneron Pharmaceuticals Inc14.36-305.31%
PBYIPuma Biotechnology Inc14.45-306.68%
INCYIncyte Corp14.49-307.19%
NAGENiagen Bioscience Inc14.82-311.89%
XOMAXOMA Corp14.95-313.82%
TGTXTG Therapeutics Inc15.67-324.14%
EXELExelixis Inc16.60-337.38%
CPRXCatalyst Pharmaceuticals Inc17.36-348.19%
MDXGMimedx Group Inc17.52-350.53%
CTMXCytomX Therapeutics Inc19.63-380.67%
ASNDAscendis Pharma A/S23.50-436.06%
HALOHalozyme Therapeutics Inc23.83-440.71%
ARGXArgen X SE24.24-446.63%
XOMAOXOMA Corp25.34-462.43%
VRTXVertex Pharmaceuticals Inc25.57-465.61%
XOMAPXOMA Corp25.67-467.08%
RPRXRoyalty Pharma plc - Class A27.78-497.19%
SLNOSoleno Therapeutics Inc29.02-514.92%
LGNDLigand Pharmaceuticals Inc - Class B31.77-554.27%
APLSApellis Pharmaceuticals Inc39.02-658.00%
BMRNBiomarin Pharmaceutical Inc40.22-675.16%
KRYSKrystal Biotech Inc40.45-678.38%
ONCBeiGene Ltd58.89-942.20%
PHARPharming Group N.V.68.77-1083.48%
TECHBio-Techne Corp74.88-1170.87%
VCELVericel Corp87.95-1357.64%
GMABGenmab118.15-1789.51%
ALNYAlnylam Pharmaceuticals Inc123.07-1859.91%
TLXTelix Pharmaceuticals Ltd135.58-2038.83%
CORTCorcept Therapeutics Inc185.65-2754.76%